semaglutide for liver Wegovy Treated Severe Disease in Large Clinical Trial How weight loss drugs could

Losing weight triggers all kinds of biological responses that undermine the loss

Triple G is one medication that has demonstrated weight loss up to 24.2% at 48 weeks in a mid-stage trial

ORahilly, Stephen (2021-04)

One concern about the medications, however, is that Now, a large-scale study has found no significant increase in thyroid cancer risk for people with type 2 diabetes on GLP-1 agonists compared with people treated with The study appears in Bjrn Pasternak, MD, PhD, lead author, and principal researcher at the Department of Medicine, Solna, at Karolinska Institutet in Sweden, explained why the team conducted the the study